{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:28:53Z","timestamp":1790641733353,"version":"4.1.0"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1097\/iae.0b013e3181754231","type":"journal-article","created":{"date-parts":[[2008,9,3]],"date-time":"2008-09-03T08:00:13Z","timestamp":1220428813000},"page":"1082-1086","source":"Crossref","is-referenced-by-count":46,"title":["THE SAFETY OF INTRAOCULAR METHOTREXATE IN SILICONE-FILLED EYES"],"prefix":"10.1097","volume":"28","author":[{"given":"PAUL W.","family":"HARDWIG","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JOSE S.","family":"PULIDO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SOPHIE J.","family":"BAKRI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210130","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S0161-6420(01)00576-0","article-title":"Methotrexate therapy for chronic noninfectious uveitis: analysis of a case series of 160 patients.","volume":"108","author":"Samson","year":"2001","journal-title":"Ophthalmology"},{"key":"R2-8-20210130","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1001\/archopht.1997.01100160322009","article-title":"Intravitreal methotrexate as an adjunctive treatment of intraocular lymphoma.","volume":"115","author":"Fishburne","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"R3-8-20210130","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/S0161-6420(02)01125-9","article-title":"Role of intravitreal methotrexate in the management of primary central nervous system lymphoma with ocular involvement.","volume":"109","author":"Smith","year":"2002","journal-title":"Ophthalmology"},{"key":"R4-8-20210130","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.ajo.2006.06.002","article-title":"Intraocular methotrexate in ocular diseases other than primary central nervous system lymphoma.","volume":"142","author":"Hardwig","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"R5-8-20210130","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1136\/bjo.83.4.448","article-title":"Intravitreal chemotherapy for the treatment of recurrent intraocular lymphoma.","volume":"83","author":"de Smet","year":"1999","journal-title":"Br J Ophthalmol"},{"key":"R6-8-20210130","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1001\/archopht.119.10.1518","article-title":"Pharmacokinetics and toxicity of intravitreal chemotherapy for primary intraocular lymphoma.","volume":"119","author":"Velez","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"R7-8-20210130","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0161-6420(85)34063-0","article-title":"Clearance of intravitreal fluorouracil. Normal and aphakic vitrectomized eyes.","volume":"92","author":"Jarus","year":"1985","journal-title":"Ophthalmology"},{"key":"R8-8-20210130","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0002-9394(14)75908-2","article-title":"The clearance of intravitreal gentamicin.","volume":"92","author":"Cobo","year":"1981","journal-title":"Am J Ophthalmol"},{"key":"R9-8-20210130","first-page":"593","article-title":"Intravitreal injection of gentamicin in rabbits. Effect of inflammation and pigmentation on half-life and ocular distribution.","volume":"20","author":"Kane","year":"1981","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R10-8-20210130","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0002-9394(82)90130-1","article-title":"The clearance of intravitreal triamcinolone acetonide.","volume":"93","author":"Schindler","year":"1982","journal-title":"Am J Ophthalmol"},{"key":"R11-8-20210130","first-page":"378","article-title":"Clearance of intravitreal 3H-fluorouracil.","volume":"16","author":"Case","year":"1985","journal-title":"Ophthalmic Surg"},{"key":"R12-8-20210130","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1167\/iovs.05-0880","article-title":"Methotrexate reduces the complications of endophthalmitis resulting from intravitreal injection compared with dexamethasone in a rabbit model.","volume":"47","author":"Deng","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R14-8-20210130","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jcrs.2004.01.014","article-title":"Visual acuity measurements.","volume":"30","author":"Holladay","year":"2004","journal-title":"J Cataract Refract Surg"},{"key":"R15-8-20210130","first-page":"845","article-title":"Toxicity of antineoplastic drugs in vitrectomy infusion fluids.","volume":"14","author":"Barrada","year":"1983","journal-title":"Ophthalmic Surg"},{"key":"R16-8-20210130","first-page":"247","article-title":"In vitro evaluation of cellular inhibitory potential of various antineoplastic drugs and dexamethasone.","volume":"16","author":"Fiscella","year":"1985","journal-title":"Ophthalmic Surg"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00006982-200809000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T22:16:25Z","timestamp":1618352185000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006982-200809000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":15,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0b013e3181754231","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}